hydroxychloroquine has been researched along with Convalescence in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Convalescence: The period of recovery following an illness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The kinetics of IgG antibodies after coronavirus disease 2019 (COVID-19) remain poorly understood." | 1.62 | Determinants of IgG antibodies kinetics after severe and critical COVID-19. ( Aboubakar, F; Belkhir, L; De Greef, J; Gerard, L; Pilette, C; Pothen, L; Scohy, A; Yildiz, H; Yombi, JC; Zech, F, 2021) |
| "One patient experienced a torsade de pointes requiring cardiac resuscitation and one died due to multiple organ failure." | 1.56 | Early experience with remdesivir in SARS-CoV-2 pneumonia. ( Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durante-Mangoni, E | 1 |
| Andini, R | 1 |
| Bertolino, L | 1 |
| Mele, F | 1 |
| Florio, LL | 1 |
| Murino, P | 1 |
| Corcione, A | 1 |
| Zampino, R | 1 |
| García-Moguel, I | 1 |
| Díaz Campos, R | 1 |
| Alonso Charterina, S | 1 |
| Fernández Rodríguez, C | 1 |
| Fernández Crespo, J | 1 |
| Fu, C | 1 |
| Zhang, W | 1 |
| Li, H | 1 |
| Bai, Y | 1 |
| Bae, KT | 1 |
| Wang, M | 1 |
| Xu, J | 1 |
| Shao, F | 1 |
| Rivas, N | 1 |
| Espinoza, M | 1 |
| Loban, A | 1 |
| Luque, O | 1 |
| Jurado, J | 1 |
| Henry-Hurtado, N | 1 |
| Goodridge, A | 1 |
| De Greef, J | 1 |
| Scohy, A | 1 |
| Zech, F | 1 |
| Aboubakar, F | 1 |
| Pilette, C | 1 |
| Gerard, L | 1 |
| Pothen, L | 1 |
| Yildiz, H | 1 |
| Belkhir, L | 1 |
| Yombi, JC | 1 |
| Manganotti, P | 1 |
| Bellavita, G | 1 |
| Tommasini, V | 1 |
| D Acunto, L | 1 |
| Fabris, M | 1 |
| Cecotti, L | 1 |
| Furlanis, G | 1 |
| Sartori, A | 1 |
| Bonzi, L | 1 |
| Buoite Stella, A | 1 |
| Pesavento, V | 1 |
6 other studies available for hydroxychloroquine and Convalescence
| Article | Year |
|---|---|
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver | 2020 |
COVID-19, severe asthma, and biologics.
Topics: Acetates; Adrenergic beta-2 Receptor Antagonists; Amoxicillin-Potassium Clavulanate Combination; Ant | 2020 |
FDG PET/CT evaluation of a patient recovering from COVID-19.
Topics: Albumins; Betacoronavirus; Budesonide; Clinical Laboratory Techniques; Convalescence; Coronavirus In | 2020 |
Case Report: COVID-19 Recovery from Triple Infection with
Topics: Adult; Antitubercular Agents; Antiviral Agents; Betacoronavirus; Coinfection; Convalescence; Coronav | 2020 |
Determinants of IgG antibodies kinetics after severe and critical COVID-19.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Viral; Body Mass Index; Convalescence; COVID-19; COVID-19 | 2021 |
Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients.
Topics: Action Potentials; Acute Disease; Aged; Anti-Bacterial Agents; Biomarkers; Convalescence; COVID-19; | 2021 |